Cardiorobotics, a developer of a robotic catheter for heart procedures, has raised $6.6 million of a planned $12.5 million round of equity and rights financing, according to an SEC filing. The firm lists a Raynham, MA, address. Xconomy wrote about the firm’s “snake” robotics platform in 2009, after the company took in $11.6 million in Series A financing to develop its technology for procedures to fix irregular heart beats or a condition called atrial fibrillation. The firm’s previous investors include Eagle Ventures, Pittsburgh Life Sciences Greenhouse, and Slater Technology Fund.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
